Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis
Evaluation of The Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis
1 other identifier
interventional
54
1 country
1
Brief Summary
Objective: The aim of the present study was to investigate the treatment efficacy of TECAR therapy, a modern application that has been increasingly used in recent years, compared to conventional physical therapy applications in the treatment of knee osteoarthritis, according to the evaluation of the clinical findings of patients. Methods: A total of 54 patients, aged between 40 and 75 years, were randomly divided into two groups. Both groups received CPT. Group 2 received TECAR therapy in addition to CPT, applied three times a week for two weeks, for a total of 6 sessions. All patient's knee joint range of motion (ROM) was measured goniometrically, isometric quadriceps muscle strength was measured, and pain levels were assessed using the Visual Analog Scale (VAS), and disability levels were assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) before treatment, at the end of treatment, at 1 month, and at 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable knee-osteoarthritis
Started Mar 2023
Shorter than P25 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 23, 2023
CompletedFirst Submitted
Initial submission to the registry
May 6, 2024
CompletedFirst Posted
Study publicly available on registry
May 17, 2024
CompletedMay 17, 2024
May 1, 2024
5 months
May 6, 2024
May 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Visual Analog Scale (VAS)
0 min , 10 is maximum pain score
Before and the after treatment 0th day , 1th month, 3rd month
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
This 24-item index comprises three subscales: pain, stiffness, and physical function, each measured on a five-point Likert scale ranging from "none" to "extreme."
Before and the after treatment 0th day, 1th month, 3rd month
Range of Motion (ROM)
Flexion and extension of the knee joint were measured using a universal goniometer relative to reference points.
Before and the after treatment 0th day, 1th month, 3rd month
Secondary Outcomes (1)
The Diers Myoline Isometric Muscle Strength Measurement System
Before and the end of treatment 0th day, 1th month, 3rd month
Study Arms (2)
conventional physical therapy (CPT)
EXPERIMENTALGroup 1 (HP, TENS, knee isometric and theraband exercise) to painful side knee area, two weeks, five times a week, 10 sessions.
conventional physical therapy (CPT) and TECAR therapy
EXPERIMENTALGroup 2 (HP, TENS, knee isometric and theraband exercise) 10 sessions, two weeks, five times a week and in addition TECAR therapy, to painful side knee quadriceps and peripatellar area, three times a week for two weeks, for a total of 6 sessions.
Interventions
Transfer Energy Capacitative and Resistive Therapy
10 sessions of HP and TENS for two weeks, five times a week. HP was applied to the painful knee area for 20 minutes using a heating pad for superficial heating purposes. TENS was applied to the painful knee area for 20 minutes at 80 Hz frequency
Eligibility Criteria
You may qualify if:
- months of conservative treatment for unresponsive knee pain
- Kellgren-Lawrence grade 2-3 on radiographic evaluation
- Agreed to participate in the study.
You may not qualify if:
- History of physical therapy (electrotherapy/exercise) in the past 3 months
- Intra-articular injection therapy in the past 3 months,
- History of surgery or trauma to the affected knee
- Inflammatory or neurological disease affecting the lower extremities
- Active vasculitis or severe peripheral vascular disease
- Pregnancy or lactation
- Diagnosed restless legs syndrome
- Neoplasia
- Local sensory impairment,
- Local or systemic acute infections
- Severe osteoporosis
- Pacemaker
- Psychiatric disorder and cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Özge TEZEN
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2024
First Posted
May 17, 2024
Study Start
March 13, 2023
Primary Completion
August 23, 2023
Study Completion
November 23, 2023
Last Updated
May 17, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
participant data will not share